JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120297

Phorbol 12-myristate 13-acetate (PMA), PKC activator

Be the first to review this product! Submit a review

|

(66 Publications)

Phorbol 12-myristate 13-acetate (PMA) (CAS:16561-29-8) (ab120297) is a potent protein kinase C (PKC) activator in vivo and in vitro. Binds to C1 domain of PKC, induces membrane translocation and enzyme activation. Molecular weight (MW): 616.8; Purity>99%.

- Available in different sizes to fit your experimental needs. Larger volume format available upon request
- Proven performance: cited in over 65 publications
11 Images
Chemical Structure - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • Chemical Structure

Lab

Chemical Structure - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

2D chemical structure image of ab120297, Phorbol 12-myristate 13-acetate (PMA), PKC activator

Functional Studies - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • FuncS

Unknown

Functional Studies - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

Serum starved HeLa cells were incubated at 37°C for 60 minutes with vehicle control (0 μM) and different concentrations of phorbol 12-myristate 13-acetate (PMA) (ab120297) in DMSO. Increased expression of PKC mu (phospho S916) (ab81218) correlates with an increase in phorbol 12-myristate 13-acetate (PMA) concentration, as described in literature.

Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 20 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 3% milk before being incubated with ab81218 at 1 μg/ml and ab8227 at 1 μg /ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.

Immunocytochemistry/ Immunofluorescence - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized THP-1 (human monocytic leukemia cell line) cells, untreated or treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours, then treated with 100ng/ml lipopolysaccharide (LPS) for 7 hours, with 1 μg/ml Brefeldin A (BFA) added after 4 hours, labeling MCP1 with ab214819 at 1/50 dilution followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining in THP-1 treated cells.

The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Flow Cytometry - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • Flow Cyt

Lab

Flow Cytometry - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

Flow cytometric analysis of 4% paraformaldehyde-fixed, 0.1% Tween-20-permeabilized THP-1 (human monocytic leukemia cell line) cell line, treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h (Right) / Untreated control (Left) labeling MCP1 with ab214891 at 1/500 dilution. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • sELISA

Unknown

Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

Sandwich ELISA - IFN gamma Human ELISA Kit (ab46025)

Jurkat were stimulated for 48 hours with 50 ng x mL-1 of PMA (ab120297) and 1 μM Ionomycin (ab120116) and PBMCs were stimulated for 48 hours with 2 % PHA-M (LifeTechnologies). Cell free supernatants were tested, showing results after background signal was subtracted (duplicates +/- SD).

Western blot - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • WB

Supplier Data

Western blot - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 23129404 and PMID : 6423641).

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

All lanes:

Western blot - Anti-Interferon gamma antibody [RM1245] (<a href='/en-us/products/primary-antibodies/interferon-gamma-antibody-rm1245-ab322926'>ab322926</a>) at 1/1000 dilution

Lane 1:

Untreated No-GFP-CD16.NK-92 (CD16 ectopically expressed natural killer(NK-92®) cell with no GFP tag) whole cell lysate at 20 µg

Lane 2:

No-GFP-CD16.NK-92 treated with 80nM PMA(TPA) (ab120297) and 3uM Ionomycin (<a href='/en-us/products/biochemicals/ionomycin-ca2-salt-ca2-ionophore-ab120116'>ab120116</a>) for 5 hours, 300 ng/ml BFA was added for last 4 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 17 kDa,19 kDa,23 kDa,36 kDa

false

Exposure time: 92s

Immunoprecipitation - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • IP

Lab

Immunoprecipitation - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

CD69 was immunoprecipitated from 0.35 mg Daudi (human Burkitt's lymphoma lymphoblast) treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours whole cell lysate with ab233396 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab233396 at 1/5,000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5,000 dilution.

Lane 1 : Daudi (human Burkitt's lymphoma lymphoblast) treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours whole cell lysate 10 μg (Input).
Lane 2 : ab233396 IP in Daudi treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab233396 in Daudi treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA, ab120297) for 24 hours whole cell lysate (-).

Blocking/Dilution buffer : 5% NFDM/TBST.

false

Exposure time: 30s

Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • sELISA

Unknown

Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

Sandwich ELISA - IL-1ra (Interleukin-1ra) Mouse ELISA Kit (ab113348)

IL-1Ra detected in supernatants from RAW 246.7 control cells (C) or cells stimulated for 24 hours with 50 ng x mL-1 of PMA (ab120297) (P), or 24 hours with PMA and 1 ug x mL-1 of LPS (Sigma) (P+L) for the last 6 hours. Results shown after background signal was subtracted (duplicates +/- SD).

Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • sELISA

Unknown

Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

Sandwich ELISA - IL-6 (Interleukin-6) Mouse ELISA Kit (ab100712).

IL-6 detected in supernatants from RAW 246.7 control cells (C) or cells stimulated for 24 hours with 50 ng x mL-1 of PMA (ab120297) (P), or 24 hours with PMA and 1 ug x mL-1 of LPS (Sigma) (P+L) for the last 6 hours. Results shown after background signal was subtracted (duplicates +/- SD).

Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • sELISA

Unknown

Sandwich ELISA - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

Sandwich ELISA - TNF alpha Human ELISA Kit (ab100654)

TNFa detected in supernatants from control cells (C) or cells stimulated for 24 hours with 50 ng x mL-1 of PMA (ab120297) (P), and PMA with the addition of 1 ug x mL-1 of LPS (Sigma) (P+L) for the last 6 hours. Results shown after background signal was subtracted (duplicates +/- SD).

Immunoprecipitation - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)
  • IP

Lab

Immunoprecipitation - Phorbol 12-myristate 13-acetate (PMA), PKC activator (AB120297)

MCP1 was immunoprecipitated from 0.35 mg of THP-1 (human monocytic leukemia cell line) treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h whole cell lysate with ab214819 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab214819 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

Lane 1 : THP-1 treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h whole cell lysate 10 μg (Input).

Lane 2 : ab214819 IP in THP-1 treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab214819 in THP-1 treated with 80nM Phorbol-12-myristate-13-acetate (PMA, ab120297) for 24h, then treated with 100ng/ml lipopolysaccharide (LPS) for 4h, then together with 1μg/ml Brefeldin A (BFA) for another 3h whole cell lysate.

Blocking and dilution buffer : 5% NFDM/TBST.

false

Exposure time: 30s

Key facts

CAS number

16561-29-8

Purity

>99%

Form

Solid

form

Molecular weight

616.8 Da

Molecular formula

C<sub>3</sub><sub>6</sub>H<sub>5</sub><sub>6</sub>O<sub>8</sub>

PubChem

27924

Nature

Synthetic

Solubility

Available in multiple formatsab120297: Soluble in DMSO to 100 mM and in ethanol to 10 mM; ab147465: Supplied in DMSO (10mM).

Biochemical name

Phorbol 12-myristate 13-acetate

Biological description

Potent nanomolar activator of protein kinase C in vivo and in vitro. Binds to C1 domain of protein kinase C, induces membrane translocation and enzyme activation. Also reported to have actions on non-kinase proteins including chimaerins, RasGRP and Unc-13/Munc-13. Extremely potent mouse skin tumor promoter.

Canonical smiles

CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C

Isomeric smiles

CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C

InChi

InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3/t24-,27+,28-,30-,32-,34-,35-,36-/m1/s1

InChiKey

PHEDXBVPIONUQT-RGYGYFBISA-N

IUPAC Name

[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Protein Kinase C (PKC) family consists of serine/threonine kinases involved in various cellular processes. This family includes PKC delta PKC mu (also known as Protein Kinase D or PKD) PKC epsilon PKC beta 2 PKC gamma PKC zeta PKC eta PKC theta (PRKCQ) PKC iota and PKC nu (PRKD3). These proteins are activated by PMA (phorbol myristate acetate) and other phorbol esters like phorbol-12-myristate-13-acetate which mimic diacylglycerol a natural activator. Mechanically they phosphorylate a wide range of substrates reaching their molecular weight of around 77-100 kDa. PKCs are expressed in multiple tissues playing distinct roles in cellular signaling.
Biological function summary

The PKC family influences many cellular processes including cell proliferation differentiation and survival. These proteins interact with signaling complexes to regulate cellular responses. PKC isoforms participate in assembling or modulating these complexes in response to external stimuli like hormones or stress. Phorbols like PMA activate PKCs altering intracellular signaling pathways. PKCs' role in tumor promotion through these processes makes them significant in cancer research.

Pathways

PKC proteins are essential components in the MAPK/ERK pathway influencing gene expression and cell cycle. They also integrate signals in the PI3K/AKT pathway impacting cell growth and apoptosis. Through these pathways PKC interacts with proteins like RAF MEK in MAPK/ERK and PDK1 mTOR in PI3K/AKT coordinating multiple cellular responses to environmental changes.

PKCs have been implicated in cancer and cardiovascular diseases. In cancer PKC mutations or aberrant regulation promote tumorigenic processes such as uncontrolled cell division and survival often in connection with proteins like Ras or Bcl-2. In cardiovascular diseases altered PKC activity affects heart muscle function and development interacting with proteins like Troponin I or C. Understanding PKC regulation offers potential therapeutic insights for treating these conditions.

Product protocols

Publications (66)

Recent publications for all applications. Explore the full list and refine your search

Journal of cellular and molecular medicine 29:e70525 PubMed40159652

2025

Unravelling Cancer Immunity: Coagulation.Sig and BIRC2 as Predictive Immunotherapeutic Architects.

Applications

Unspecified application

Species

Unspecified reactive species

Ziang Yao,Jun Fan,Yucheng Bai,Jiakai He,Xiang Zhang,Renquan Zhang,Lei Xue

Nature communications 16:3012 PubMed40148355

2025

Medium from human iPSC-derived primitive macrophages promotes adult cardiomyocyte proliferation and cardiac regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Xiao,Hao Zhang,Xu Liu,Pengfei Xu,Heng Du,Jiawan Wang,Jianghua Shen,Yujing Li,Yuhan Wang,Chuting He,Haiping Feng,Jingfang Liu,Yanan Zhou,Siqi Liu,Zeyu Gao,Jingyi Zang,Jinmiao Bi,Tie-Shan Tang,Qi Gu,Tuo Wei,Jun Wang,Moshi Song

Journal of nanobiotechnology 23:239 PubMed40121481

2025

Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon.

Applications

Unspecified application

Species

Unspecified reactive species

Man Li,Lisen Lu,Qiuhong Bao,Minghui Zhou,Bin Nie,Yanchao Liu,Kai Shu,Ting Lei,Mingxin Zhu

Journal of functional biomaterials 15: PubMed39728155

2024

Impact of Particle Size and Sintering Temperature on Calcium Phosphate Gyroid Structure Scaffolds for Bone Tissue Engineering.

Applications

Unspecified application

Species

Unspecified reactive species

Romina Haydeé Aspera-Werz,Guanqiao Chen,Lea Schilonka,Islam Bouakaz,Catherine Bronne,Elisabeth Cobraiville,Grégory Nolens,Andreas Nussler

Exploration (Beijing, China) 4:20240027 PubMed39713206

2024

Bioengineer mesenchymal stem cell for treatment of glioma by IL-12 mediated microenvironment reprogramming and nCD47-SLAMF7 mediated phagocytosis regulation of macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Man Li,Lisen Lu,Qungen Xiao,Ali Abdi Maalim,Bin Nie,Yanchao Liu,Ulf D Kahlert,Kai Shu,Ting Lei,Mingxin Zhu

International journal of molecular sciences 25: PubMed39457012

2024

Disruption of Erythritol Catabolism via the Deletion of Fructose-Bisphosphate Aldolase (Fba) and Transaldolase (Tal) as a Strategy to Improve the Rev1 Vaccine.

Applications

Unspecified application

Species

Unspecified reactive species

Aitor Elizalde-Bielsa,Leticia Lázaro-Antón,María Jesús de Miguel,Pilar M Muñoz,Raquel Conde-Álvarez,Amaia Zúñiga-Ripa

iScience 27:110622 PubMed39252956

2024

MMP9 drives ferroptosis by regulating GPX4 and iron signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Flobater I Gawargi,Paras K Mishra

iScience 27:109823 PubMed38756418

2024

NET-targeted nanoparticles for antithrombotic therapy in pregnancy.

Applications

Unspecified application

Species

Unspecified reactive species

Yijie Zhou,Lin Xu,Pingsong Jin,Na Li,Xuehai Chen,Anyu Yang,Hongbo Qi

Journal of ovarian research 17:101 PubMed38745186

2024

Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation.

Applications

Unspecified application

Species

Unspecified reactive species

Min Wang,Yangyan Sun,Rui Gu,Yan Tang,Guorong Han,Shaojie Zhao

Cellular & molecular immunology 21:604-619 PubMed38689020

2024

Immunopeptidome mining reveals a novel ERS-induced target in T1D.

Applications

Unspecified application

Species

Unspecified reactive species

Lina Wang,Shushu Yang,Gaohui Zhu,Jie Li,Gang Meng,Xiaoling Chen,Mengjun Zhang,Shufeng Wang,Xiangqian Li,Yu Pan,Yi Huang,Li Wang,Yuzhang Wu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com